Trials / Completed
CompletedNCT07302191
High-Intensity Interval or Concurrent Exercise on Oxidative Stress and Inflammation in Obese Women
Comparable Reductions in Health Biomarkers Following High-Intensity Interval or Concurrent Training in Obese Postmenopausal Women
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- University of Valladolid · Academic / Other
- Sex
- Female
- Age
- 50 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Introduction: Menopause is associated with body composition change, an increase in the cardio-metabolic risk factor for oxidative stress. Nevertheless, it has been suggested that regular physical training is an effective non-pharmacological intervention to reduce oxidative stress and cardio-metabolic disorders in menopausal individuals. Therefore, the present study was conducted to compare the effects of twelve weeks of high-intensity interval training (HIIT) and concurrent (Conc) and on body composition, cardio-metabolic indices and oxidative stress in sedentary obese postmenopausal women. Materials and methods: Forty-five menopausal obese women voluntarily participated and were randomly assigned into three groups: a) HIIT (6-12×60s of high intensity training (85-95% HRMax) and then running for 60 seconds with low intensity (55-60% HRMax)), b) concurrent endurance (performed on training with 55-75% HRMax) and strength training (including two sets in eight exercise stations with 55-75% 1RM)) and c) control group. Training programs were done for twelve weeks, 3 times per week. Body composition, cardio-metabolic indices and oxidative stress markers were measured before and after twelve weeks of exercise training program.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | High-Intensity Interval | HIIT consisted of alternating high- (90-95 % HR\_max) and low-intensity (55-60 % HR\_max) aerobic bouts |
| BEHAVIORAL | concurrent training | combined aerobic and resistance exercises |
| BEHAVIORAL | Control Group | usual daily routines |
Timeline
- Start date
- 2025-09-02
- Primary completion
- 2025-11-20
- Completion
- 2025-12-08
- First posted
- 2025-12-24
- Last updated
- 2025-12-31
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT07302191. Inclusion in this directory is not an endorsement.